Table 1 Patients’ demographic and comorbidity characteristics.
Total population (n = 100) | Non-cardiotoxicity (n = 59) | Cardiotoxicity (n = 41) | P value | |
|---|---|---|---|---|
Baseline ejection fraction (%) | 50.25 ± 9.19 | 47.46 ± 10.96 | 54.27 ± 2.64 | 0.001* |
Age | 54.53 ± 13.72 | 55.68 ± 14.19 | 52.88 ± 13.02 | 0.32 |
Height | 162.33 ± 7.60 | 162.86 ± 8.23 | 161.56 ± 6.61 | 0.40 |
Weight | 69.78 ± 12.70 | 70.96 ± 13.57 | 68.1 ± 11.28 | 0.27 |
BMI (Kg/m2) | 26.24 ± 4.44 | 26.46 ± 4.44 | 25.91 ± 4.48 | 0.54 |
Female Sex, n,(%) | 84 (84%) | 45 (76%) | 39 (91%) | 0.007* |
Diabetes, n,(%) | 18 (18%) | 11 (18.64%) | 8(19.51%) | 0.29 |
Hypertension, n,(%) | 21 (21%) | 12 (20.33%) | 9 (22%) | 0.84 |
Dyslipidemia, n,(%) | 25 (25%) | 14 (23.7%) | 11 (26.8%) | 0.81 |
Previous Cardiovascular Disease, n,(%) | 16 (16%) | 13 (22%) | 3 (7.3%) | 0.056 |
Smoking, n,(%) | 9 (9%) | 6 (10.2%) | 3 (7.3%) | 0.45 |
Alcohol, n,(%) | 0 (0%) | 0 (0%) | 0 (0%) | 0.99 |
Metastasis, n,(%) | 19 (19%) | 11 (18.6%) | 8 (19.5%) | 0.91 |
